Xiapex
DrugXiapex administration will follow SMPC
NCT Number: NCT01444729
An agreement has been made to conduct a post-approval commitment study that provides supplementary information relating to the use of Xiapex® as well as other non-pharmacological treatments for Dupuytren's contracture by health care professionals in a real world clinical setting.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Auxilium Investigational Site, Bergen, Norway
phase 4, open label, multi-center, prospective non-interventional descriptive
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
none
Xiapex administration will follow SMPC
Non-pharmacological treatment
Time frame: an expected average of 5 weeks
Time frame: an expected average of 5 weeks
Time frame: at day 1
Endo USA Inc., a Keenova Therapeutics Company
Industry
A Non-Interventional Post Approval Commitment Study To Evaluate The Outcomes Of The Various Treatment Options For Dupuytren's Contracture
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00528606
Connective Tissue Diseases, Contracture
Los Angeles, California, United States
View Trial DetailsNCT01407068
Connective Tissue Diseases, Contracture
Tucson, Arizona, United States
View Trial DetailsNCT00528931
Connective Tissue Diseases, Contracture
Burbank, California, United States
View Trial DetailsNCT01674634
Connective Tissue Diseases, Contracture
Phoenix, Arizona, United States
View Trial Details